Humanum PML-Rara Fusion Gene Mutationem
Product Name
HWTS-TM017aHumanum PML-Rara Fusion Gene Mutationem Deprehensio Kit (Fluorescence PCR)
Epidemiology
Acutus Promyelocytic Leukemia (APL) est specialis generis acuti myeloid leukemia (AML). Circiter XCV% of APL aegris sunt cum a speciali cytogenetic mutatio, nimirum T (XV, XVII) (Q22; Q21), qui facit PML Gene XV et Retinoic Acidum receptor α Forma PML-Rara Fusion Gene. Debitum ad alia breakpoints PML gene, in PML-Rara Fusion Gene potest dividitur in tempore generis (l type), brevis type (s type) et Variant Type (V%, XL% % respectively.
Channel
| Fam | PML-Rara Fusion Gene |
| ROX | Internum |
Technical parametri
| Repono | ≤, XVIII ℃ in tenebris |
| PLUTEUM-vitae | IX menses |
| Specimen Type | medullas |
| CV | <5.0% |
| LOD | M copies / ml. |
| Specifica | Non est crucem-reactivity cum aliis eget genes BCR, ABL, E2A-PBX1, MLL-AF4, AML1, etto, Tel-AML1 FUSION |
| COMPRESSUS | Applicari Biosystems (VII) D Real-vicis PCR ratio Applicari Biosystems (VII) D ieiunium realis-vicis PCR systems Quantstudio®V Real-vicis PCR Systems Slan-96P Real-vicis PCR systems (Hongshi Medical Technology Co., Ltd.) LightCycler®CDLXXX realis-vicis PCR ratio Verus-vicis PCR (IX) DC PRCE PCR Deprehensio ratio (FQD-96a, Hangzhou Bioer Technology) MA-(VI) Real-vicis quantitatis scelerisque cycler (Suzhou Molalarray Co., Ltd.) BIOD CFX96 Real-vicis PCR ratio BIOD CFX Opus XCVI Real-vicis PCR ratio |
ADMODO
Commendatur extraction Reagent: RNAPRep pura sanguis totalis RNA extractionem Ornamentum (DP433). Extractione debet agi secundum IFU.
